A study drug safely minimizes severity for those with a painful eye condition, a new clinical trial at the University of Michigan Kellogg Eye Center has found.
Shantell M. Kirkendoll
Shantell M. Kirkendoll is the senior communication representative for the University of Michigan Health System. She leverages social media and media relations to tell compelling stories about research and health care. She was a Knight Journalism Fellow at the Centers for Disease Control and Prevention and joined the University of Michigan Health System in 2009. Prior to that she was a print journalist for 20 years.
A study including more than 4,000 people with either type 1 or type 2 diabetes — all under age 21 — revealed a troubling eye health trend.
With input from U-M trauma experts, elderly and obese dummies are being used to help car manufacturers create safer vehicles for today’s drivers.
Not all hospitals have the clinicians to diagnose and treat an eye disease in premature babies. But they can use technology to connect with ophthalmologists elsewhere.
The in-office eye treatment, now offered at U-M, can help improve outcomes for keratoconus or other corneal diseases.
Scientists can now grow 3-D models of various organs from stem cells, creating new ways to study disease.